Identification of Glycogen Synthase Kinase 3α as a Therapeutic Target in Melanoma

Pigment Cell and Melanoma Research - United Kingdom
doi 10.1111/pcmr.12156
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Tissue-Specific Analysis of Glycogen Synthase Kinase-3α (GSK-3α) in Glucose Metabolism: Effect of Strain Variation

PLoS ONE
Multidisciplinary
2011English

Kinase Inhibitor Screening Identifies CDK4 as a Potential Therapeutic Target for Melanoma

International Journal of Oncology
Cancer ResearchOncology
2015English

Identification of Glycogen Synthase as a New Substrate for Stress-Activated Protein Kinase 2b/P38beta

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2004English

Glycogen Synthase Kinase-3

International Journal of Alzheimer's Disease
AgingCognitive NeuroscienceMolecular NeuroscienceNeurologyBehavioral NeuroscienceCellular
2011English

Potential Therapeutic Effect of Glycogen Synthase Kinase 3 Inhibition Against Human Glioblastoma

Clinical Cancer Research
Cancer ResearchOncology
2009English

Protein Kinase C as a Therapeutic Target

Clinical Cancer Research
Cancer ResearchOncology
2006English

Glycogen Synthase Kinase 3î’ Prediction as Primary Cellular Target to Mediate Anti Hepatitis C Effect of Nitazoxanide

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY
2013English

Identification of a Glycogen Synthase Kinase-3β Inhibitor That Attenuates Hyperactivity in CLOCK Mutant Mice

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2011English

Target Identification Reveals Lanosterol Synthase as a Vulnerability in Glioma

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy